Has Scott Rahhal, MD received payments from drug or device companies?

Yes. Drug and device makers reported $782 in general payments to Scott Rahhal, MD across 31 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Scott Rahhal, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Scott Rahhal, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Scott Rahhal, MD

Orthopaedic Surgery · Tulsa, OKNPI 1366443046

Payments from drug & device makers

$782in general payments, 2019–2025

Across 31 payments — averaging $25.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Smith+Nephew$372
Stryker$243
Pacira Therapeutics, Inc.$77
Orthofix Medical, Inc.$33
Ferring Pharmaceuticals Inc.$30
Vertex$28

What the payments were for

Food & beverage$782100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Smith+Nephew	14	$372
Stryker	8	$243
Pacira Therapeutics, Inc.	4	$77
Orthofix Medical, Inc.	2	$33
Ferring Pharmaceuticals Inc.	2	$30
Vertex	1	$28

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Regeneten$106

How this compares

$782 in reported general payments places this provider in the 15th percentile of 263 orthopaedic surgery providers in Oklahoma.

See all orthopaedic surgery providers in Oklahoma →

Medicare billing

Part B allowed, 2024

$137,761

Medicare patients

281

Services billed

1,991

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Ondansetron OdtOndansetron	98	$899
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen	66	$891
Meloxicam	143	$660
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	49	$520
Tramadol Hcl	11	$30

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Tulsa

Yogesh MittalTulsa$6.7M
Brian ChalkinTulsa$1.9M
Sarat KunapuliTulsa$170K
Kasra AhmadiniaTulsa$138K
Keivan AbtahiTulsa$77K
Rodney PlasterTulsa$61K
Garrett WallerTulsa$52K
Landon StallingsTulsa$46K
Travis SmallTulsa$39K
Blake ShockleyTulsa$39K

See the full list for Oklahoma →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →